featured
Efficacy of Eribulin for Metastatic Breast Cancer Based on Localization of Specific Secondary Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Scientific Reports
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Eribulin for Metastatic Breast Cancer Based on Localization of Specific Secondary Metastases: A Post Hoc Analysis
Sci Rep 2020 Jul 08;[EPub Ahead of Print], J O'Shaughnessy, J Cortes, C Twelves, LJ Goldstein, K Alexis, R Xie, C Barrios, T UenoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.